“José Gabay” Course: Interview to Ricardo Lluberas

After the successful 8th edition of the ProEducar “José Gabay” Course (which took place on August 1st, 2017, at the Hilton Buenos Aires Hotel), it is time to assess its outcomes. In this case, Dr. Ricardo Lluberas, who was the SOLACI president at the time of the event, analyzed the results of the aforementioned course and SOLACI’s educational work in the promotion of interventional cardiology in Latin America.
Dr. Ricardo Lluberas.

What are your thoughts after another edition (the eighth) of the ProEducar “José Gabay” Course?

Clearly, this course marked the growth and development of ProEducar and its activities. Firstly, due to the number of participants, which has been constant over time. There is even a rising trend in that sense. This year, about 140 participants enrolled; a clear success.

 

Secondly, this growth I mentioned was reflected in the scientific level of all presentations. Highly-renowned specialists took part in the event and shared all of their expertise. That is incredibly significant and adds much value to the course, because, beyond the literature addressed, young physicians have proven to be highly inclined to listen and learn from those who are more experienced in medical practice.

 

How important is the fact that SOLACI, as an institution, fosters these events and scientific activities?

Since its foundation, SOLACI has had an essential educational role. One of its goals is, precisely, to train young professionals and educate the new generations of interventional cardiologists in Latin America. Activities such as the “José Gabay” Course are a step towards such objective.

 

As regards the future, SOLACI and the ProEducar board intend to establish and develop means for continuous training, beyond the special courses already in place.

 

How would you characterize the level of interventional cardiology in Latin America? And in Argentina?

In Latin America, levels vary according to the actual circumstances in each location. In some places, the level of interventional cardiology is extremely high in all aspects (research, clinical practice, etc.). However, some developing places somewhat justify the presence of SOLACI and its outreach to these structures. In this sense, beyond its educational function, SOLACI seeks to develop interventional cardiology in all of Latin America.

 

As regards Argentina, its level is unparalelled: interventional cardiology in Argentina has made great contributions to SOLACI, it still does. The Argentine school offers an important tradition that is passed on to new generations who continue with this development.

 

What would you say to young interventional cardiologists who have just graduated and are starting with their professional career?

I would tell them to pour their hearts and souls into it, above all else. That is what matters the most. Then, to focus on training, obviously. First comes attitude, the spiritual aspect, one’s commitment with the specialty and the patients, always within the ethical framework by which all physicians should abide. Then comes training, which is a constant throughout this process. In conclusion, I would tell them that there is no good medical practice without passion or training.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...